Docosahexaenoic Acid Augmentation of Cortical Attention Networks in ADHD
Phase of Trial: Phase III
Latest Information Update: 16 Oct 2018
Price : $35 *
At a glance
- Drugs Docosahexaenoic acid (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 17 Mar 2017 Status changed from active, no longer recruiting to completed.
- 02 Nov 2016 Status changed from recruiting to active, no longer recruiting.
- 03 Aug 2016 Planned End Date changed from 1 Sep 2016 to 1 Sep 2017.